 | • レポートコード：GIR201115643 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、免疫腫瘍学の世界市場を調査対象にし、免疫腫瘍学の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（免疫チェックポイント阻害剤、サイトカインベース免疫療法、癌ワクチン、CAR-T細胞療法、その他）、用途別分析（病院、ドラッグストア、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Bristol-Myers Squibb、Gilead Sciences Inc.、AstraZeneca, Plc、Merck & Co., Inc.、Novartis、Roche AG、Dendreon Pharmaceuticals、Sanofi S.A.、Merck KGaA ・企業別売上、市場シェア ・免疫腫瘍学の地域別市場分析 ・免疫腫瘍学の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・免疫腫瘍学のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・免疫腫瘍学のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・免疫腫瘍学の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・免疫腫瘍学の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・免疫腫瘍学の種類別市場規模2015-2020：免疫チェックポイント阻害剤、サイトカインベース免疫療法、癌ワクチン、CAR-T細胞療法、その他 ・免疫腫瘍学の用途別市場規模2015-2020：病院、ドラッグストア、その他 ・免疫腫瘍学の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Immuno-Oncology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.3% in the forecast period of 2020 to 2025 and will expected to reach USD 56950 million by 2025, from USD 33390 million in 2019.
The Immuno-Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Immuno-Oncology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Immuno-Oncology market has been segmented into:
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
By Application, Immuno-Oncology has been segmented into:
Hospitals
Drugstores
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Immuno-Oncology market presented in the report. This section sheds light on the sales growth of different regional and country-level Immuno-Oncology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immuno-Oncology market.
The report offers in-depth assessment of the growth and other aspects of the Immuno-Oncology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Immuno-Oncology Market Share Analysis
Immuno-Oncology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Immuno-Oncology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immuno-Oncology sales, revenue and market share for each player covered in this report.
The major players covered in Immuno-Oncology are:
Bristol-Myers Squibb
Gilead Sciences Inc.
AstraZeneca, Plc
Merck & Co., Inc.
Novartis
Roche AG
Dendreon Pharmaceuticals
Sanofi S.A.
Merck KGaA
1 Immuno-Oncology Market Overview
1.1 Product Overview and Scope of Immuno-Oncology
1.2 Classification of Immuno-Oncology by Type
1.2.1 Global Immuno-Oncology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Immuno-Oncology Revenue Market Share by Type in 2019
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Cytokine-Based Immunotherapy
1.2.5 Cancer Vaccines
1.2.6 CAR-T Cell Therapy
1.2.7 Others
1.3 Global Immuno-Oncology Market by Application
1.3.1 Overview: Global Immuno-Oncology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Immuno-Oncology Market by Regions
1.4.1 Global Immuno-Oncology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Immuno-Oncology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Immuno-Oncology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Immuno-Oncology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immuno-Oncology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Immuno-Oncology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immuno-Oncology Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences Inc.
2.2.1 Gilead Sciences Inc. Details
2.2.2 Gilead Sciences Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences Inc. SWOT Analysis
2.2.4 Gilead Sciences Inc. Product and Services
2.2.5 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca, Plc
2.3.1 AstraZeneca, Plc Details
2.3.2 AstraZeneca, Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca, Plc SWOT Analysis
2.3.4 AstraZeneca, Plc Product and Services
2.3.5 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck & Co., Inc. SWOT Analysis
2.4.4 Merck & Co., Inc. Product and Services
2.4.5 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche AG
2.6.1 Roche AG Details
2.6.2 Roche AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche AG SWOT Analysis
2.6.4 Roche AG Product and Services
2.6.5 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dendreon Pharmaceuticals
2.7.1 Dendreon Pharmaceuticals Details
2.7.2 Dendreon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dendreon Pharmaceuticals SWOT Analysis
2.7.4 Dendreon Pharmaceuticals Product and Services
2.7.5 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi S.A.
2.8.1 Sanofi S.A. Details
2.8.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi S.A. SWOT Analysis
2.8.4 Sanofi S.A. Product and Services
2.8.5 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck KGaA
2.9.1 Merck KGaA Details
2.9.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck KGaA SWOT Analysis
2.9.4 Merck KGaA Product and Services
2.9.5 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Immuno-Oncology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Immuno-Oncology Players Market Share
3.2.2 Top 10 Immuno-Oncology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Immuno-Oncology Revenue and Market Share by Regions
4.2 North America Immuno-Oncology Revenue and Growth Rate (2015-2020)
4.3 Europe Immuno-Oncology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Immuno-Oncology Revenue and Growth Rate (2015-2020)
4.5 South America Immuno-Oncology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)
5 North America Immuno-Oncology Revenue by Countries
5.1 North America Immuno-Oncology Revenue by Countries (2015-2020)
5.2 USA Immuno-Oncology Revenue and Growth Rate (2015-2020)
5.3 Canada Immuno-Oncology Revenue and Growth Rate (2015-2020)
5.4 Mexico Immuno-Oncology Revenue and Growth Rate (2015-2020)
6 Europe Immuno-Oncology Revenue by Countries
6.1 Europe Immuno-Oncology Revenue by Countries (2015-2020)
6.2 Germany Immuno-Oncology Revenue and Growth Rate (2015-2020)
6.3 UK Immuno-Oncology Revenue and Growth Rate (2015-2020)
6.4 France Immuno-Oncology Revenue and Growth Rate (2015-2020)
6.5 Russia Immuno-Oncology Revenue and Growth Rate (2015-2020)
6.6 Italy Immuno-Oncology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Immuno-Oncology Revenue by Countries
7.1 Asia-Pacific Immuno-Oncology Revenue by Countries (2015-2020)
7.2 China Immuno-Oncology Revenue and Growth Rate (2015-2020)
7.3 Japan Immuno-Oncology Revenue and Growth Rate (2015-2020)
7.4 Korea Immuno-Oncology Revenue and Growth Rate (2015-2020)
7.5 India Immuno-Oncology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Immuno-Oncology Revenue and Growth Rate (2015-2020)
8 South America Immuno-Oncology Revenue by Countries
8.1 South America Immuno-Oncology Revenue by Countries (2015-2020)
8.2 Brazil Immuno-Oncology Revenue and Growth Rate (2015-2020)
8.3 Argentina Immuno-Oncology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Immuno-Oncology by Countries
9.1 Middle East & Africa Immuno-Oncology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Immuno-Oncology Revenue and Growth Rate (2015-2020)
9.3 UAE Immuno-Oncology Revenue and Growth Rate (2015-2020)
9.4 Egypt Immuno-Oncology Revenue and Growth Rate (2015-2020)
9.5 South Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Immuno-Oncology Revenue and Market Share by Type (2015-2020)
10.2 Global Immuno-Oncology Market Forecast by Type (2019-2024)
10.3 Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2025)
10.4 Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2025)
10.5 Cancer Vaccines Revenue Growth Rate (2015-2025)
10.6 CAR-T Cell Therapy Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Immuno-Oncology Market Segment by Application
11.1 Global Immuno-Oncology Revenue Market Share by Application (2015-2020)
11.2 Immuno-Oncology Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Drugstores Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Immuno-Oncology Market Size Forecast (2021-2025)
12.1 Global Immuno-Oncology Market Size Forecast (2021-2025)
12.2 Global Immuno-Oncology Market Forecast by Regions (2021-2025)
12.3 North America Immuno-Oncology Revenue Market Forecast (2021-2025)
12.4 Europe Immuno-Oncology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Immuno-Oncology Revenue Market Forecast (2021-2025)
12.6 South America Immuno-Oncology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Immuno-Oncology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Immuno-Oncology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Immuno-Oncology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Immuno-Oncology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Immuno-Oncology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 6. Bristol-Myers Squibb Immuno-Oncology Major Business
Table 7. Bristol-Myers Squibb Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 8. Bristol-Myers Squibb SWOT Analysis
Table 9. Bristol-Myers Squibb Immuno-Oncology Product and Solutions
Table 10. Bristol-Myers Squibb Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Gilead Sciences Inc. Corporate Information, Location and Competitors
Table 12. Gilead Sciences Inc. Immuno-Oncology Major Business
Table 13. Gilead Sciences Inc. Immuno-Oncology Total Revenue (USD Million) (2018-2019)
Table 14. Gilead Sciences Inc. SWOT Analysis
Table 15. Gilead Sciences Inc. Immuno-Oncology Product and Solutions
Table 16. Gilead Sciences Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. AstraZeneca, Plc Corporate Information, Location and Competitors
Table 18. AstraZeneca, Plc Immuno-Oncology Major Business
Table 19. AstraZeneca, Plc Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 20. AstraZeneca, Plc SWOT Analysis
Table 21. AstraZeneca, Plc Immuno-Oncology Product and Solutions
Table 22. AstraZeneca, Plc Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 24. Merck & Co., Inc. Immuno-Oncology Major Business
Table 25. Merck & Co., Inc. Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 26. Merck & Co., Inc. SWOT Analysis
Table 27. Merck & Co., Inc. Immuno-Oncology Product and Solutions
Table 28. Merck & Co., Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Immuno-Oncology Major Business
Table 31. Novartis Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Immuno-Oncology Product and Solutions
Table 34. Novartis Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche AG Corporate Information, Location and Competitors
Table 36. Roche AG Immuno-Oncology Major Business
Table 37. Roche AG Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 38. Roche AG SWOT Analysis
Table 39. Roche AG Immuno-Oncology Product and Solutions
Table 40. Roche AG Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Dendreon Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Dendreon Pharmaceuticals Immuno-Oncology Major Business
Table 43. Dendreon Pharmaceuticals Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 44. Dendreon Pharmaceuticals SWOT Analysis
Table 45. Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
Table 46. Dendreon Pharmaceuticals Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sanofi S.A. Corporate Information, Location and Competitors
Table 48. Sanofi S.A. Immuno-Oncology Major Business
Table 49. Sanofi S.A. Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 50. Sanofi S.A. SWOT Analysis
Table 51. Sanofi S.A. Immuno-Oncology Product and Solutions
Table 52. Sanofi S.A. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck KGaA Corporate Information, Location and Competitors
Table 54. Merck KGaA Immuno-Oncology Major Business
Table 55. Merck KGaA Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 56. Merck KGaA SWOT Analysis
Table 57. Merck KGaA Immuno-Oncology Product and Solutions
Table 58. Merck KGaA Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Immuno-Oncology Revenue (Million USD) by Players (2015-2020)
Table 60. Global Immuno-Oncology Revenue Share by Players (2015-2020)
Table 61. Global Immuno-Oncology Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Immuno-Oncology Revenue Market Share by Regions (2015-2020)
Table 63. North America Immuno-Oncology Revenue by Countries (2015-2020)
Table 64. North America Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 65. Europe Immuno-Oncology Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Immuno-Oncology Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Immuno-Oncology Revenue by Countries (2015-2020)
Table 68. South America Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Immuno-Oncology Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 71. Global Immuno-Oncology Revenue (Million USD) by Type (2015-2020)
Table 72. Global Immuno-Oncology Revenue Share by Type (2015-2020)
Table 73. Global Immuno-Oncology Revenue Forecast by Type (2021-2025)
Table 74. Global Immuno-Oncology Revenue by Application (2015-2020)
Table 75. Global Immuno-Oncology Revenue Share by Application (2015-2020)
Table 76. Global Immuno-Oncology Revenue Forecast by Application (2021-2025)
Table 77. Global Immuno-Oncology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Immuno-Oncology Picture
Figure 2. Global Immuno-Oncology Revenue Market Share by Type in 2019
Figure 3. Immune Checkpoint Inhibitors Picture
Figure 4. Cytokine-Based Immunotherapy Picture
Figure 5. Cancer Vaccines Picture
Figure 6. CAR-T Cell Therapy Picture
Figure 7. Others Picture
Figure 8. Immuno-Oncology Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Drugstores Picture
Figure 11. Others Picture
Figure 12. Global Immuno-Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Immuno-Oncology Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Immuno-Oncology Revenue Market Share in 2019
Figure 21. Global Top 10 Players Immuno-Oncology Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Immuno-Oncology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Immuno-Oncology Revenue Market Share by Regions (2015-2020)
Figure 25. Global Immuno-Oncology Revenue Market Share by Regions in 2018
Figure 26. North America Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 27. Europe Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 29. South America Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 31. North America Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Figure 32. North America Immuno-Oncology Revenue Market Share by Countries in 2019
Figure 33. USA Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 34. Canada Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 36. Europe Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Immuno-Oncology Revenue Market Share by Countries in 2019
Figure 38. Germany Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 39. UK Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 40. France Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 41. Russia Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 42. Italy Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Immuno-Oncology Revenue Market Share by Countries in 2019
Figure 45. China Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 46. Japan Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 47. Korea Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 48. India Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 50. South America Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Figure 51. South America Immuno-Oncology Revenue Market Share by Countries in 2019
Figure 52. Brazil Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Immuno-Oncology Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 57. UAE Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)
Figure 60. Global Immuno-Oncology Revenue Share by Type (2015-2020)
Figure 61. Global Immuno-Oncology Revenue Share by Type in 2019
Figure 62. Global Immuno-Oncology Market Share Forecast by Type (2021-2025)
Figure 63. Global Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020)
Figure 64. Global Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2020)
Figure 65. Global Cancer Vaccines Revenue Growth Rate (2015-2020)
Figure 66. Global CAR-T Cell Therapy Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Immuno-Oncology Revenue Share by Application (2015-2020)
Figure 69. Global Immuno-Oncology Revenue Share by Application in 2019
Figure 70. Global Immuno-Oncology Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Drugstores Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Immuno-Oncology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Immuno-Oncology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Immuno-Oncology Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Immuno-Oncology Revenue Market Forecast (2021-2025)
Figure 78. Europe Immuno-Oncology Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Immuno-Oncology Revenue Market Forecast (2021-2025)
Figure 80. South America Immuno-Oncology Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Immuno-Oncology Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
免疫腫瘍学治療の世界市場 2020年 Market Overview The global Immuno-Oncology Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Immuno-Oncology Tre…- オンコロジーベース前臨床CROの世界市場 2020年 Market Overview The global Oncology Based Preclinical CRO market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.8% in the forecast period of 2020 to 2025 and will expected to reach USD 494.7 million by 2025, from USD 316.4 million in 2019. The Oncolo…
- オンコロジージェネリック注射薬の世界市場 2020年 Market Overview The global Oncology Generic Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Ge…
- インターベンショナル腫瘍デバイスの世界市場 2020年 Market Overview The Interventional Oncology Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- マイクロバイオーム治療の世界市場 2020年 Market Overview The Microbiome Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…